Provided by Tiger Trade Technology Pte. Ltd.

ETHZilla Corporation

10.64
+1.1712.35%
Post-market: 10.63-0.0100-0.09%16:52 EST
Volume:1.72M
Turnover:18.55M
Market Cap:205.36M
PE:-0.07
High:11.29
Open:10.65
Low:10.26
Close:9.47
52wk High:174.60
52wk Low:6.58
Shares:19.30M
Float Shares:12.31M
Volume Ratio:2.13
T/O Rate:13.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-154.9059
EPS(LYR):-154.9059
ROE:-96.47%
ROA:-27.79%
PB:0.46
PE(LYR):-0.07

Loading ...

Company Profile

Company Name:
ETHZilla Corporation
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
4
Office Location:
2875 South Ocean Blvd,Suite 200,Palm Beach,Florida,United States
Zip Code:
33480
Fax:
- -
Introduction:
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

Directors

Name
Position
McAndrew Rudisill
Chief Executive Officer and Executive Chairman
Andrew Suckling
Director
Crystal Heter
Director
Jason New
Director
Ryan L. Smith
Director

Shareholders

Name
Position
McAndrew Rudisill
Chief Executive Officer and Executive Chairman
Eric R. Van Lent
Chief Accounting Officer and Secretary